What You Need to Know About Medicinal Mushrooms, Psilocybin and Health Canada’s Regulations

Medicinal mushrooms, otherwise known as “magic mushrooms” is the term that is used to describe mushrooms that contain natural, active ingredients (hallucinogens), such as Psilocybin and Psilocin. In Canada, Psilocybin (chemical name: 3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and Psilocin (chemical name: 3–[2–(dimethylamino)ethyl]–4–hydroxyindole) are controlled under Schedule III of the Controlled Drugs and Substances Act (CDSA). This means that activities

Read More >

Health Canada’s Operational Changes to Cannabis Program Requirements

cannabis regulations

On May 12, 2020, Health Canada issued an email notice to federal cannabis licence holders announcing several operational changes being made to cannabis program requirements. It was noted that these changes are permanent, taking effect immediately and are to be followed with online guidance in the near future. The changes implemented by Health Canada stem

Read More >

Health Canada’s Updates on Cannabis Licensing and COVID-19

On March 24, 2020, Health Canada advised federal cannabis licence holders of its decision to temporarily adjust its approach to administering and enforcing the Cannabis Act & Regulations, due to COVID-19 and its shift to teleworking. Health Canada stated that temporary adjustments will be in place until May 1, 2020, at which time they will

Read More >

Health Canada’s Consultation on Cannabis Health Products

Cannabis Health Products consultation

On June 19, 2019, Health Canada launched a consultation on the potential market for cannabis health products that would not require practitioner oversight. The purpose of the consultation is to seek feedback from Canadians and industry on the kinds of products they would be interested in purchasing, manufacturing or selling, if such products were to

Read More >

Health Canada’s Changes to Cannabis Licensing

On May 8, Health Canada published a statement introducing changes being made to cannabis licensing. Health Canada is implementing these adjustments as a result of many factors including feedback from applicants regarding the time it takes to get licensed, the number of applicants already in queue for a cannabis licence and to better allocate resources

Read More >

Health Canada’s Voluntary Recall Guide for Cannabis

On February 11, Health Canada published the Cannabis Voluntary Recall Guide which provides information on the requirements related to voluntary recalls of cannabis and cannabis products under the Cannabis Act and Regulations. A recall is intended to minimize the risk associated with a problem or potential problem with the cannabis or cannabis product by removing

Read More >

We use cookies to display personalized content, analyze site traffic, provide recommendations, and ensure you have a great browsing experience. By continuing to use our site, you consent to our use of cookies. Privacy Policy.